Clinical Validation of a Proteomic Biomarker Threshold for Increased Risk of Spontaneous Preterm Birth and Associated Clinical Outcomes: A Replication Study

Clinical Validation of a Proteomic Biomarker Threshold for Increased Risk of Spontaneous Preterm Birth and Associated Clinical Outcomes: A Replication Study

Preterm births are the leading cause of neonatal death in the United States. Previously, a spontaneous preterm birth (sPTB) predictor based on the ratio of two proteins, IBP4/SHBG, was validated as a predictor of sPTB in the Proteomic Assessment of Preterm Risk (PAPR) study. In particular, a proteom...

Full description

Saved in:
Bibliographic Details
Main Authors: Julja Burchard, Ashoka D. Polpitiya, Angela C. Fox, Todd L. Randolph, Tracey C. Fleischer, Max T. Dufford, Thomas J. Garite, Gregory C. Critchfield, J. Jay Boniface, George R. Saade, Paul E. Kearney
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
preterm birth
IBP4
SHBG
biomarkers
Medicine
R
Online Access:https://doaj.org/article/0ce762e2134e431990fa9acca088a426
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/0ce762e2134e431990fa9acca088a426

Similar Items